Suppr超能文献

细胞因子信号传导中JAK1假激酶结构域的特征分析

Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling.

作者信息

Raivola Juuli, Haikarainen Teemu, Silvennoinen Olli

机构信息

Faculty of Medicine and Life Sciences, Tampere University, 33014 Tampere, Finland.

Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, 00014 Helsinki, Finland.

出版信息

Cancers (Basel). 2019 Dec 27;12(1):78. doi: 10.3390/cancers12010078.

Abstract

The Janus kinase-signal transducer and activator of transcription protein (JAK-STAT) pathway mediates essential biological functions from immune responses to haematopoiesis. Deregulated JAK-STAT signaling causes myeloproliferative neoplasms, leukaemia, and lymphomas, as well as autoimmune diseases. Thereby JAKs have gained significant relevance as therapeutic targets. However, there is still a clinical need for better JAK inhibitors and novel strategies targeting regions outside the conserved kinase domain have gained interest. In-depth knowledge about the molecular details of JAK activation is required. For example, whether the function and regulation between receptors is conserved remains an open question. We used JAK-deficient cell-lines and structure-based mutagenesis to study the function of JAK1 and its pseudokinase domain (JH2) in cytokine signaling pathways that employ JAK1 with different JAK heterodimerization partner. In interleukin-2 (IL-2)-induced STAT5 activation JAK1 was dominant over JAK3 but in interferon-γ (IFNγ) and interferon-α (IFNα) signaling both JAK1 and heteromeric partner JAK2 or TYK2 were both indispensable for STAT1 activation. Moreover, IL-2 signaling was strictly dependent on both JAK1 JH1 and JH2 but in IFNγ signaling JAK1 JH2 rather than kinase activity was required for STAT1 activation. To investigate the regulatory function, we focused on two allosteric regions in JAK1 JH2, the ATP-binding pocket and the αC-helix. Mutating L633 at the αC reduced basal and cytokine induced activation of STAT in both JAK1 wild-type (WT) and constitutively activated mutant backgrounds. Moreover, biochemical characterization and comparison of JH2s let us depict differences in the JH2 ATP-binding and strengthen the hypothesis that de-stabilization of the domain disturbs the regulatory JH1-JH2 interaction. Collectively, our results bring mechanistic understanding about the function of JAK1 in different receptor complexes that likely have relevance for the design of specific JAK modulators.

摘要

Janus激酶-信号转导子及转录激活蛋白(JAK-STAT)通路介导了从免疫反应到造血作用等重要的生物学功能。JAK-STAT信号传导失调会引发骨髓增殖性肿瘤、白血病和淋巴瘤,以及自身免疫性疾病。因此,JAK作为治疗靶点具有重要意义。然而,临床上仍需要更好的JAK抑制剂,针对保守激酶结构域以外区域的新策略也引起了人们的关注。需要深入了解JAK激活的分子细节。例如,受体之间的功能和调节是否保守仍是一个悬而未决的问题。我们使用JAK缺陷细胞系和基于结构的诱变方法,研究JAK1及其假激酶结构域(JH2)在采用JAK1与不同JAK异二聚体伙伴的细胞因子信号通路中的功能。在白细胞介素-2(IL-2)诱导的STAT5激活中,JAK1比JAK3占主导地位,但在干扰素-γ(IFNγ)和干扰素-α(IFNα)信号传导中,JAK1和异源伙伴JAK2或TYK2对于STAT1激活都是必不可少的。此外,IL-2信号传导严格依赖于JAK1的JH1和JH2,但在IFNγ信号传导中,STAT1激活需要JAK1的JH2而不是激酶活性。为了研究调节功能,我们聚焦于JAK1 JH2中的两个变构区域,即ATP结合口袋和αC螺旋。在αC处突变L633会降低JAK1野生型(WT)和组成型激活突变体背景下STAT的基础激活和细胞因子诱导激活。此外,对JH2的生化特性分析和比较使我们描绘出JH2 ATP结合的差异,并强化了这样一种假设,即该结构域的不稳定会扰乱调节性的JH1-JH2相互作用。总的来说,我们的结果为JAK1在不同受体复合物中的功能带来了机制上的理解,这可能与设计特定的JAK调节剂相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de1/7016850/e88e5a0fd3a3/cancers-12-00078-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验